GLP-1 and next-generation obesity medicines are transforming weight management. They can deliver clinically meaningful weight loss and important health benefits, partly by reducing appetite and calorie intake. This lower calorie intake is central to weight loss – but it also creates new challenges around digestive comfort, nutrient adequacy, protein intake, hydration, muscle and bone preservation, and long-term maintenance.